224 - Promoting Diversity, Equity, and Inclusion in Regenerative Medicine: Expanding Access and Innovation in PM&R

Regenerative medicine has emerged as a transformative field within Physical Medicine and Rehabilitation (PM&R), offering innovative approaches to restore, repair, and regenerate damaged tissues and organs. The integration of regenerative therapies into PM&R has been driven by the need to address the limitations of traditional treatments, which often focus on symptom management rather than addressing the underlying causes of musculoskeletal and neurological conditions. Techniques such as stem cell therapy, platelet-rich plasma (PRP) therapy, and extracellular matrix-based therapies aim to enhance the body’s natural healing processes.

Design:

This study evaluates the accessibility of regenerative medicine in Arizona, with a particular focus on the distribution of clinics offering stem cell therapy, PRP therapy, and prolotherapy, as well as insurance coverage. The geographic distribution of clinics was analyzed, with attention to the disparity between urban and rural areas. Data were collected on clinic locations across the state, comparing the availability of services in Arizona.

Results:

The analysis revealed a significant geographic disparity in the availability of regenerative medicine services. Clinics offering therapies such as stem cell and PRP therapy were predominantly located in urban centers like Phoenix and Tucson, with an urban-to-rural clinic ratio of nearly 10:1. While some insurance plans provided coverage for regenerative therapies, many gaps remained, especially in rural areas where access to these advanced treatments was limited. This geographic imbalance suggests that patients in rural regions face more significant challenges in accessing regenerative medicine, potentially exacerbating healthcare inequalities.

Conclusions:

As regenerative medicine continues to evolve, it holds the potential to revolutionize the treatment of musculoskeletal and neurological conditions, marking a significant shift from traditional symptom-focused approaches. However, to fully realize this potential, it is crucial to prioritize diversity, equity, and inclusion in the implementation of these therapies.